BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30312935)

  • 1. Estimation of seizures prevalence in ischemic strokes after thrombolytic therapy.
    Nesselroth D; Gilad R; Namneh M; Avishay S; Eilam A
    Seizure; 2018 Nov; 62():91-94. PubMed ID: 30312935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between different acute stroke therapies and development of post stroke seizures.
    Naylor J; Thevathasan A; Churilov L; Guo R; Xiong Y; Koome M; Chen Z; Chen Z; Liu X; Kwan P; Campbell BCV
    BMC Neurol; 2018 May; 18(1):61. PubMed ID: 29724190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-Stroke Seizures Is Associated with Low Alberta Stroke Program Early CT Score.
    Chen Z; Churilov L; Koome M; Chen Z; Naylor J; Kwan P; Yan B
    Cerebrovasc Dis; 2017; 43(5-6):259-265. PubMed ID: 28259886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
    Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
    J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
    Merkler AE; Salehi Omran S; Gialdini G; Lerario MP; Yaghi S; Elkind MSV; Navi BB
    Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urgent carotid intervention is safe after thrombolysis for minor to moderate acute ischemic stroke.
    Bazan HA; Zea N; Jennings B; Smith TA; Vidal G; Sternbergh WC
    J Vasc Surg; 2015 Dec; 62(6):1529-38. PubMed ID: 26412434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA.
    Dong Y; Cao W; Ren J; Nair DS; Parker S; Jahnel JL; Swanson-Devlin TG; Beck JM; Mathews M; McNeil CJ; Upadhyaya M; Gao Y; Dong Q; Wang DZ
    PLoS One; 2015; 10(8):e0131487. PubMed ID: 26247772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
    J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the ischemic stroke patients whose seizures occur at stroke presentation at a single institution in Eastern China.
    Cheng JH; Zhang Z; Ye Q; Ye ZS; Xia NG
    J Neurol Sci; 2018 Apr; 387():46-50. PubMed ID: 29571870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of seizures following initial ischemic stroke in a community-based cohort: The Framingham Heart Study.
    Stefanidou M; Das RR; Beiser AS; Sundar B; Kelly-Hayes M; Kase CS; Devinsky O; Seshadri S; Friedman D
    Seizure; 2017 Apr; 47():105-110. PubMed ID: 28364691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of tissue plasminogen activator eligibility by sex in the Greater Cincinnati/Northern Kentucky Stroke Study.
    Madsen TE; Khoury JC; Alwell KA; Moomaw CJ; Kissela BM; De Los Rios La Rosa F; Woo D; Adeoye O; Flaherty ML; Khatri P; Ferioli S; Kleindorfer D
    Stroke; 2015 Mar; 46(3):717-21. PubMed ID: 25628307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous thrombolysis for stroke increases over time at primary stroke centers.
    Prabhakaran S; McNulty M; O'Neill K; Ouyang B
    Stroke; 2012 Mar; 43(3):875-7. PubMed ID: 22135073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.